Imlifidase enables AAV gene therapy in a seropositive Crigler-Najjar patient: On the verge of a paradigm shift. - Do Cao J; Gao-Desliens J; Valent A; Knuchel-Legendre N; Colpin C; Guyon H; Winstedt L; Leborgne C; Perret G; Ronzitti G; Labrune P (Molecular therapy : the journal of the American Society of Gene Therapy, 2026)